PDB39 - Health care costs among type 2 diabetes mellitus patients initiating glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy
| Autor: | Johnston, S.S., Nguyen, H., Felber, E., Cappell, K., Nelson, J., Chu, B.C., Kalsekar, I. |
|---|---|
| Zdroj: | In Value in Health May 2014 17(3):A244-A244 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect